Evidence map›Paper›PMID 39050621›Full record

ArticleIEEE journal of translational engineering in health and medicine2024

A Dual-Camera Eye-Tracking Platform for Rapid Real-Time Diagnosis of Acute Delirium: A Pilot Study.

Ahmed Al-Hindawi, Marcela Vizcaychipi, Yiannis Demiris

Registry-linked trialAbstract read
In one paragraph

Article in IEEE journal of translational engineering in health and medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07136207 (Research on Delirium Recognition in Neurocritical Patients Based on Facial Expression Behavior Patterns), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07136207 recruitingnot on this mapstarted 2025, after this paper: background citation

Research on Delirium Recognition in Neurocritical Patients Based on Facial Expression Behavior Patterns

TypeobservationalSponsorBeijing Tiantan HospitalRan2025 to 2026Enrolled1,000ConditionsDelirium, Artificial Intelligence (AI)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmed Al-HindawiPersonal Robotics LaboratoryDepartment of Electrical and Electronic EngineeringImperial College London SW7 2AZ London U.K.ORCID 0000-0003-4547-6056
Marcela VizcaychipiDepartment of AnaesthesiaPain Medicine and Intensive Care, Chelsea and Westminster Hospital NHS Foundation Trust SW10 9NH London U.K.ORCID 0000-0001-7894-873X
Yiannis DemirisPersonal Robotics LaboratoryDepartment of Electrical and Electronic EngineeringImperial College London SW7 2AZ London U.K.ORCID 0000-0003-4917-3343

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDelirium, an acute confusional state, affects 20-80% of patients in Intensive Care Units (ICUs), one in three medically hospitalized patients, and up to 50% of all patients who have had surgery. Its development is associated with short- and long-term morbidity, and increased risk of death. Yet, we lack any rapid, objective, and automated method to diagnose delirium. Here, we detail the prospective deployment of a novel dual-camera contextual eye-tracking platform. We then use the data from this platform to contemporaneously classify delirium.

resultsWe recruited 42 patients, resulting in 210 (114 with delirium, 96 without) recordings of hospitalized patients in ICU across two centers, as part of a prospective multi-center feasibility pilot study. All recordings made with our platform were usable for analysis. We divided the collected data into training and validation cohorts based on the data originating center. We trained two Temporal Convolutional Network (TCN) models that can classify delirium using a pre-existing manual scoring system (Confusion Assessment Method in ICU (CAM-ICU)) as the training target. The first model uses eye movements only which achieves an Area Under the Receiver Operator Curve (AUROC) of 0.67 and a mean Average Precision (mAP) of 0.68. The second model uses the point of regard, the part of the scene the patient is looking at, and increases the AUROC to 0.76 and the mAP to 0.81. These models are the first to classify delirium using continuous non-invasive eye-tracking but will require further clinical prospective validation prior to use as a decision-support tool. CLINICAL IMPACT: Eye-tracking is a biological signal that can be used to identify delirium in patients in ICU. The platform, alongside the trained neural networks, can automatically, objectively, and continuously classify delirium aiding in the early detection of the deteriorating patient. Future work is aimed at prospective evaluation and clinical translation.

Indexed as

DeliriumEye-Tracking TechnologyAgedAged, 80 and overFemaleHumansIntensive Care UnitsMaleMiddle AgedPilot ProjectsProspective StudiesDeliriumeye-trackingintensive care medicine

Identifiers

PMID39050621
PMCPMC11268942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.